Sygnis SA (WSE:SYG)
Poland · Delayed Price · Currency is PLN 2.480
+0.080 (3.33%)
At close: Oct 31, 2025
Sygnis Market Cap
Sygnis has a market cap or net worth of 66.92 million as of November 3, 2025. Its market cap has increased by 310.40% in one year.
Market Cap
66.92M
Enterprise Value
72.64M
Revenue
15.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.48
Market Cap Chart
Since March 16, 2012, Sygnis's market cap has increased from 6.21M to 66.92M, an increase of 977.86%. That is a compound annual growth rate of 19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 68.02M | 590.93% |
| Dec 30, 2024 | 9.84M | -56.47% |
| Dec 29, 2023 | 22.62M | -56.95% |
| Dec 30, 2022 | 52.54M | 10.53% |
| Dec 30, 2021 | 47.53M | 177.19% |
| Dec 30, 2020 | 17.15M | 568.20% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.24B |
| NEUCA | 3.34B |
| Synektik Spólka Akcyjna | 2.24B |
| Voxel | 1.60B |
| Celon Pharma | 1.16B |
| Selvita | 677.32M |
| Centrum Medyczne ENEL-MED | 511.87M |
| Bioceltix | 477.67M |